WARRINGTON Nike Lunar Eclipse 2, Pa., April 5 (UPI) -- Discovery Labs said Wednesday it got its second approvable letter from the FDA for its infant respiratory distress drug Surfaxin. The company said the Food and Drug Administration still has concerns a …